Nanobiotix (NBTX) — Strategic Asset Allocation Index
Nanobiotix (NBTX) has a Strategic Asset Allocation Index of 433.3% as of June 2022. Strategic assets (PP&E of $7.41 Million plus long-term investments of $352.00K) total $7.76 Million, measured against net assets of $1.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NBTX equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Nanobiotix Strategic Asset Allocation Index (2016–2021)
This chart shows how Nanobiotix's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2021. As of June 2022, the index stands at 433.3%, representing strategic assets of $7.76 Million against net assets of $1.79 Million USD. For live market cap and overall valuation, see Nanobiotix market capitalisation.
Annual Strategic Asset Allocation Index for Nanobiotix (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanobiotix from 2016 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Nanobiotix net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 30.9% | $8.28 Million | $8.19 Million | $98.00K | $26.79 Million | ▲ +19.1 pp |
| 2020 | 11.9% | $8.36 Million | $8.26 Million | $105.00K | $70.47 Million | ▼ -9.6 pp |
| 2018 | 21.5% | $3.06 Million | $2.88 Million | $176.00K | $14.24 Million | ▲ +14.7 pp |
| 2017 | 6.8% | $2.99 Million | $2.99 Million | $- | $43.92 Million | ▼ -7.2 pp |
| 2016 | 14.0% | $2.43 Million | $2.43 Million | $- | $17.40 Million | — |